378 results on '"Gazzaniga, Paola"'
Search Results
2. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
3. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
4. A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance
5. Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors
6. Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?
7. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
8. About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients
9. Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
10. Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion
11. Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer
12. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)
13. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
14. An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer
15. Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study
16. Additional file 1 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
17. Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
18. RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
19. In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity
20. Don't Worry, Your Holiness!
21. Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport: Evidence of a Reduced Drug Action in Patients After Coronary Artery Bypass Grafting
22. Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients
23. Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments
24. CIRCULATING TUMOR CELLS (CTC) IDENTIFICATION IN BLADDER CANCER USING EPCAM (EPITHELIAL CELL ADHESION MOLECULE): COMPARISON BETWEEN MANUAL AND AUTOMATED SYSTEM OF ISOLATION AND FUTURE PROSPECTIVE: MP45-09
25. MP45-16 NON-MUSCLE INVASIVE BALDDER CANCER: CIRCULATING TUMOR CELLS AND PROGNOSTIC SIGNIFICANCE
26. Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data
27. Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer
28. True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature
29. Circulating Tumor Cells: Highlight on Practical Implications
30. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
31. Circulating tumor cells in high-risk nonmetastatic colorectal cancer
32. LESSON FROM CIRCULATING TUMOR CELLS: KUHNʼS PARADIGM SHIFT IN NON-MUSCLE INVASIVE BLADDER CANCER: MP28-07
33. Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data
34. Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non–muscle-invasive Bladder Cancer
35. Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients
36. Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer
37. Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights
38. Morbidity of selective lymph node biopsy for melanoma: meta-analysis of complications
39. Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
40. Comment on: Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell–like properties
41. Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy
42. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer
43. Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
44. Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
45. Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors
46. A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer
47. WELSH RUGBY AND THE POPE: Don’t worry, Your Holiness!
48. Chemoresistance profile of circulating tumor cells: Toward a clinical benefit?
49. THE INCREASING USE OF INTRAVESICAL THERAPIES FOR STAGE T1 BLADDER CANCER COINCIDES WITH DECREASING SURVIVAL AFTER CYSTECTOMY
50. EpCAMlow Circulating Tumor Cells: Gold in the Waste
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.